Alfaxan Multidose is a drug owned by ZOETIS INC. It is protected by 6 US drug patents filed from 2021 to 2032. Out of these, 4 patents are active and 2 patents have expired. Details of Alfaxan Multidose’s patents and their expiration are given below.
Exclusivity Information
Alfaxan Multidose holds 2 exclusivitys out of which 2 have expired. Details of Alfaxan Multidose's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCE | Sep 06, 2017 |
| NCI | Jun 06, 2021 |
About Alfaxan Multidose
Alfaxan Multidose is a drug
owned by ZOETIS INC.
Alfaxan Multidose uses
Alfaxalone as the active
ingredient.
Active Ingredient:
Alfaxan Multidose uses
Alfaxalone as the active ingredient.
Check out other Drugs and Companies using
Alfaxalone ingredient.